longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

PCVX

PCVX
58.1303.71%( -2.240 )

LongbridgeAI

Vaxcyte names Luis Jodar as chief medical officer

PUBT
Sep 3, 2026 at 08:07 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Vaxcyte has appointed Luis Jodar as its new chief medical officer, where he previously served as Pfizer's chief medical officer for vaccines and infectious diseases. Additionally, David McAvoy has joined the company as chief legal officer, bringing prior experience from Teva.

  • Vaxcyte named Luis Jodar as chief medical officer. * Jodar previously served as Pfizer chief medical officer for vaccines and infectious diseases. * David McAvoy joined as chief legal officer. * McAvoy previously served as Teva chief legal officer. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxcyte Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609031605PRIMZONEFULLFEED9821280) on September 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

Login to unlock360characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

  • Sep 20, 2026 at 01:00 AMWarsh's Fed shows it's serious about taming inflation. Why Wall Street now believes it.

Related Stocks

Vaxcyte

Vaxcyte

USPCVX

-3.71%

Veracyte

Veracyte

USVCYT

Pfizer

Pfizer

USPFE